Skip to main content
OpenTrials
Completed

NCT Number: NCT03348267

Protein Supplementation and Muscle Recovery in Football

Soccer is an intermittent sport including a high number of powerful actions such as accelerations, decelerations, changes of direction, jumps and impacts that incorporate a strong eccentric component and may therefore lead to skeletal muscle damage. Indeed, match activity is associated with the onset of muscle damage and an acute inflammatory response that result in attenuated performance for as long as 1 to 3 days. In competitive soccer though, multiple matches are performed within a small-time frame resulting in inadequate muscle recovery and reduced field performance. Supplementation with milk proteins following intense exercise protocols has been shown to stimulate protein synthesis and facilitate muscle recovery. Thus, the aim of the present investigation is to examine the effects of milk protein supplementation on muscle recovery and soccer-specific performance during an in-season microcycle with two matches performed three days apart.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Exercise Biochemistry Laboratory, School of Physical Education & Sports Sciences, University of Thessaly

Trikala, 42100, Greece

About this study

In a double-blind, cross over, repeated measures design 20 men soccer players will receive either placebo (PLA) or milk protein isolate (PRO, 80% casein-20% whey) throughout recovery following two matches performed three days apart. On match days, players will receive a dose immediately after the match (PLA vs PRO: 25g of protein) and then at 3h (PLA vs PRO: 30g of protein) and 6h (PLA vs PRO: 25g of protein) post-match. On each day of the remaining days, players will consume a single dose of PLA or PRO (20g of protein) with breakfast. All players will participate in regular in-season training following matches. Field activity during both matches and daily practices will be monitored using GPS devices. Heart rate will be continuously recorded during each match and training session. Blood samples will be collected at baseline as well as 2 hours after the first match, daily for three days after the first match, 2 hours after the second match and daily for 3 days after the second match. Performance (isokinetic strength, 20-m speed, repeated sprint ability) and muscle soreness will be assessed at baseline daily for 3 days after both matches. Muscle biopsies from vastus lateralis will be collected at baseline and one day after each match.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • i) participation at elite level (top three division leagues) of soccer competition for at least five years, ii) abstain from consumption of performance-enhancing supplements, antioxidant supplements and medications (for at least 6 months before and during the study), iv) participate in at least six two-hour training sessions per week and played at least one match per week and v) non-smokers.

Exclusion criteria

  • i) a known milk intolerance or allergy, ii) a recent febrile illness, iii) history of muscle lesion, iv) lower limb trauma and v) metabolic diseases.

Treatment and study plan

Milk protein isolate

Dietary Supplement

Milk protein isolate in a powder form consisted of 80% casein and 20% whey protein. 20g were diluted into 500 ml water

Placebo

Dietary Supplement

500 mL drink that contained water (375 mL), sugar-free cordial (125 mL) and 2 g of low-calorie glucose/dextrose powder.

Primary outcomes

  1. Change in creatine kinase in plasma

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of creatine kinase will be measured in plasma

  2. Change in uric acid in plasma

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of uric acid will be measured in plasma

  3. Change in protein carbonyls in blood

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of protein carbonyls will be measured in red blood cells

  4. Change in total antioxidant capacity

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Total antioxidant capacity will be measured in plasma

  5. Change in reduced glutathione in blood

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of reduced glutathione will be measured in in red blood cells

  6. Change in oxidized glutathione in blood

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of oxidized glutathione will be measured in red blood cells

  7. Change in malondialdehyde in blood

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Concentration of malondialdehyde will be measured in serum

  8. Change in catalase activity

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Catalase activity will be measured in red blood cells

  9. Change in protein carbonyls in muscle

    Time frame: At baseline, 24h post-Match 1 and 24h post-Match 2

    Concentration of protein carbonyls will be measured in muscle

  10. Change in intracellular signaling proteins in muscle

    Time frame: At baseline, 24h post-Match 1 and 24h post-Match 2

    Phosphorylation levels of Akt, mammalian target of rapamycin (mTOR) and p70S6K will be measure using western blotting.

  11. Change in proteasome activities in muscle

    Time frame: At baseline, 24h post-Match 1 and 24h post-Match 2

    Chymotrypsin-like (CT-L), caspase-like (C-L) and trypsin-like (T-L) proteasome activities will be assayed with hydrolysis of the fluorogenic peptide LLVY-AMC, LLE-AMC and LSTR-AMC, respectively.

  12. Change in satellite cells in muscle

    Time frame: At baseline, 24h post-Match 1 and 24h post-Match 2

    Pax7, Myf5, MyoD and Myogenin will be measured in order to quantify quiescent, activated, proliferated-differentiated and fused satellite cells respectively.

  13. Change in repeated Sprint Ability

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    5 x 30 m sprints will be performed with 25 seconds rest in-between. Mean time for 5 sprints and fatigue index will be calculated.

  14. Change in countermovement jump

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Countermovement jump will be assessed on a contact platform

  15. Change in isokinetic strength of lower limbs

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Isokinetic strength will be assessed on an isokinetic dynamometer for both knee extensors and knee flexors at 120 and 180 degrees.

  16. Change in match activity

    Time frame: During Match 1 and Match 2

    Match activity will be continuously recorded during both matches using GPS technology.

  17. Change in heart rate

    Time frame: During Match 1 and Match 2

    Heart rate will be continuously recorded during both matches using the Team Polar system.

Secondary outcomes

  1. Change in delayed onset of muscle soreness

    Time frame: At baseline, at 24h, 48h and 72h post-Match 1 as well as at 24h, 48h and 72h post-Match 2

    Muscle soreness will assessed during palpation of the muscle belly and the distal region of relaxed vastus medialis, vastus lateralis and rectus femoris following three repetitions of of a full squat. Subjects will rate their DOMS on a visual analogue scale (0-10).

  2. Dietary intake

    Time frame: Over a 7-day period at baseline.

    Dietary intake will be assessed using 7-day diet recalls.

  3. Change in white blood cell count.

    Time frame: At baseline, immediately after Match 1, at 24h, 48h and 72h post-Match 1 as well as immediately after Match 2 and at 24h, 48h and 72h post-Match 2.

    White blood cell count will be measured using an automatic blood analyzer.

Sponsors and collaborators

Lead sponsor

University of Thessaly

Other

Registry information

Official study title

Effect of Milk Protein Supplementation on Muscle Recovery and Football-specific Performance During an In-season Microcycle With Two Matches

Acronym: PRO-FOOTBALL

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Nov 20, 2017
Registry last updated
Jan 30, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.